Item 1.01 Entry into a Material Definitive Agreement.
On June 1, 2020, we entered into a Material Transfer and Research Agreement (the “Agreement”) with the University of Rochester (the “University”). Pursuant to the Agreement, we will be providing the University with Ampligen and the University plans to conduct a series of in vitro experiments to test the direct antiviral activity and mechanism of action of Ampligen on SARS-CoV-2.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.